Jijie Gu

808 total citations
16 papers, 591 citations indexed

About

Jijie Gu is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Jijie Gu has authored 16 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Jijie Gu's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (6 papers) and Protein purification and stability (6 papers). Jijie Gu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (6 papers) and Protein purification and stability (6 papers). Jijie Gu collaborates with scholars based in United States, China and Germany. Jijie Gu's co-authors include Tariq Ghayur, Anwar Murtaza, Annette Schwartz, Edit Tarcsa, Zhuozhi Wang, Shaughn H. Bryant, Donna McCarthy, Christine Grinnell, Yune Z. Kunes and Emma Fung and has published in prestigious journals such as Nature Biotechnology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Jijie Gu

15 papers receiving 553 citations

Peers

Countries citing papers authored by Jijie Gu

Since Specialization

Citations

This map shows the geographic impact of Jijie Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jijie Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jijie Gu more than expected).

Fields of papers citing papers by Jijie Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jijie Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jijie Gu. The network helps show where Jijie Gu may publish in the future.

Co-authorship network of co-authors of Jijie Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Jijie Gu. A scholar is included among the top collaborators of Jijie Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jijie Gu. Jijie Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A case study of a bispecific antibody manufacturability assessment and optimization during discovery stage and its implications 2024 ·PubMed ·Shuang Wang, Weijie Zhang, (unknown), Xudong Zhang, Jing Fang, (unknown), Zhijian Chen, Jijie Gu, Zhiqiang Chen, Jianqing Xu	2
2	DISCOVERY OF NOVEL ANTI-SERUM ALBUMIN VHH AS A BUILDING BLOCK FOR PK PROLONGATION 2023 ·PubMed Central ·Yunying Chen, (unknown), Qin Yi, Donghui Wu, Jijie Gu, (unknown)	1
3	OVERCOMING TECHNICAL CHALLENGES OF BISPECIFIC AND MULTI-SPECIFIC ANTIBODIES USING NOVEL TECHNOLOGY PLATFORMS 2023 ·PubMed Central ·Jianqing Xu, Shuang Wang, (unknown), George Wang, Jijie Gu, (unknown)	0
4	Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics 2022 ·PubMed ·Weijie Zhang, Hao Wang, Nan Feng, Yifeng Li, Jijie Gu, Zhuozhi Wang	34
5	CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40 2020 ·PLoS ONE ·(unknown), Sean W. Graham, Ning Sun, Donna McCarthy, (unknown), Jamie Erickson, (unknown), Xiaochun Zhu, (unknown), Robert W. Dunstan, Susan V. Westmoreland, Namjin Chung, Tariq Ghayur, Jijie Gu	5
6	Biology drives the discovery of bispecific antibodies as innovative therapeutics 2020 ·PubMed ·(unknown), Zhuozhi Wang, Maria Moscoso‐Castro, (unknown), Can Lei, Jianqing Xu, Jijie Gu	78
7	ABT-165, a Dual Variable Domain Immunoglobulin (DVD-Ig) Targeting DLL4 and VEGF, Demonstrates Superior Efficacy and Favorable Safety Profiles in Preclinical Models 2018 ·Molecular Cancer Therapeutics ·Yingchun Li, Jonathan A. Hickson, (unknown), Deanna L. Haasch, (unknown), (unknown), Enrico L. DiGiammarino, Sanjay C. Panchal, Fang Jiang, Sarah R. Mudd, (unknown), (unknown), Wenqing Gao, Sherry L. Ralston, Louie Naumovski, Jijie Gu, Susan E. Morgan-Lappe	35
8	Potent and conditional redirected T cell killing of tumor cells using Half DVD-Ig 2017 ·Protein & Cell ·Philip D. Bardwell, Matthew Staron, Junjian Liu, Qingfeng Tao, Susanne M. Scesney, Gail Bukofzer, Luis E. Rodrı́guez, (unknown), Jennifer Wang, Qing Chang, Feng Dong, Cherrie K. Donawho, Jieyi Wang, Christine Grinnell, Edit Tarcsa, Charles W. Hutchins, Tariq Ghayur, Jijie Gu	11
9	Identification of Anti-EGFR and Anti-ErbB3 Dual Variable Domains Immunoglobulin (DVD-Ig) Proteins with Unique Activities 2015 ·PLoS ONE ·Jinming Gu, Jinsong Yang, Qing Chang, Zhihong Liu, Tariq Ghayur, Jijie Gu	15
10	Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig™) molecule 2013 ·mAbs ·Clarissa G. Jakob, Rohinton Edalji, Russell A. Judge, Enrico L. DiGiammarino, Yingchun Li, Jijie Gu, Tariq Ghayur	52
11	Generation of Dual-Variable-Domain Immunoglobulin Molecules for Dual-Specific Targeting 2011 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Jijie Gu, Tariq Ghayur	31
12	P2‐356: Guiding anti‐RAGE monoclonal antibody development for the treatment of Alzheimer's disease via imaging 2010 ·Alzheimer s & Dementia ·Feng Luo, Gerard B. Fox, Terese Seifert, Prasant Chandran, Zhen Wu, Eve Barlow, Jijie Gu, (unknown), Chung-Ming Hsieh, John E. Harlan, (unknown), Karl A. Walter, Shaun M. McLoughlin, (unknown), Hans E. Schoemaker, (unknown), Alfred Hahn, Volker Nimmrich, Martin Schmidt	1
13	Rationale and development of multispecific antibody drugs 2010 ·Expert Review of Clinical Pharmacology ·Jijie Gu, Tariq Ghayur	8
14	MM-111: a novel bispecific antibody targeting ErbB3 with potent anti-tumor activity in ErbB2 over-expressing malignancies. 2009 ·Cancer Research ·Ulrik B. Nielsen, Alexandra Huhalov, Brian D. Harms, Violette Paragas, Sharlene Adams, Jijie Gu, Stephanie A. Nguyen, Lia Luus, (unknown), (unknown), Ryan Overland, (unknown), Neeraj Kohli, Michael J. Feldhaus, Birgit Schoeberl, Charlotte F. McDonagh	6
15	The Bcl-2 Family Antagonist ABT-737 Significantly Inhibits Multiple Animal Models of Autoimmunity 2009 ·The Journal of Immunology ·Philip D. Bardwell, Jijie Gu, Donna McCarthy, (unknown), Shaughn H. Bryant, (unknown), (unknown), (unknown), Jamie Erickson, Saul H. Rosenberg, Annette Schwartz, Margaret Hugunin, Edit Tarcsa, Steven W. Elmore, Bradford L. McRae, Anwar Murtaza, Li‐Chun Wang, Tariq Ghayur	59
16	Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin 2007 ·Nature Biotechnology ·Chengbin Wu, Ying Hua, Christine Grinnell, Shaughn H. Bryant, Renee Miller, Anca Clabbers, Sahana Bose, Donna McCarthy, Rongrong Zhu, Ling C. Santora, Rachel Davis‐Taber, Yune Z. Kunes, Emma Fung, Annette Schwartz, Paul Sakorafas, Jijie Gu, Edit Tarcsa, Anwar Murtaza, Tariq Ghayur	253

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact